Abstract
The available data on the use of oral contraceptive agents in patients with sickle cell diseases is reviewed. The attitude which considers sickle cell anemia to be a contra-indication to OC's cannot be supported on the basis of available evidence. On the contrary, there are a number of reports where favorable effects of steroids on 'sickling' have been described. It is concluded that modern low-dose combined OC's are the method of choice for contraception in all patients carrying the HbS gene.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
